Picture of argenx SE logo

ARGX argenx SE Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for argenx SE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-199-478-349-720-425
Depreciation
Amortisation
Non-Cash Items43.194.193.5154240
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital305-18.8-357-401-347
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities152-398-607-863-420
Capital Expenditures-46.7-5.14-121-104-43.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-787350-226-357352
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-833345-347-461308
Financing Cash Flow Items-25.7-0.5450.438-0.371-14.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7348331,1218441,337
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash50.4845118-5341,248